カテゴリ： GlobalData, 企業調査

Biocartis Group NV (BCART)：企業の製品パイプライン分析

◆英語タイトル：Biocartis Group NV (BCART) - Product Pipeline Analysis, 2020 Update
◆商品コード：GDME194956PD
◆発行会社（調査会社）：GlobalData
◆発行日：2021年1月
◆ページ数：80
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ベルギー
◆産業分野：Medical Devices
◆販売価格オプション（消費税別）
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its Idylla is a molecular diagnostics system that provides easy access to clinical molecular diagnostic information. Biocartis also offers a wide range of oncology assays such as Idylla BRAF Mutation Test, Idylla EGFR Mutation Test, Idylla KRAS Mutation Test, and Idylla NRAS Mutation. The company has operations in Belgium and Switzerland. Biocartis is headquartered in Mechelen, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biocartis Group NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Biocartis Group NV Company Overview
Biocartis Group NV Company Snapshot
Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview
Biocartis Group NV – Pipeline Analysis Overview
Biocartis Group NV – Key Facts
Biocartis Group NV – Major Products and Services
Biocartis Group NV Pipeline Products by Development Stage
Biocartis Group NV Pipeline Products Overview
EGFR Colon Cancer Test
EGFR Colon Cancer Test Product Overview
Idylla – EGFR/BRAF+ Test
Idylla – EGFR/BRAF+ Test Product Overview
Idylla – KRAS-NRAS-BRAF Test
Idylla – KRAS-NRAS-BRAF Test Product Overview
Idylla ABC Assay
Idylla ABC Assay Product Overview
Idylla Blood Stream Infections Panel
Idylla Blood Stream Infections Panel Product Overview
Idylla Companion Diagnostic Assay
Idylla Companion Diagnostic Assay Product Overview
Idylla ctEGFR Assay
Idylla ctEGFR Assay Product Overview
Idylla Endometrium Assay
Idylla Endometrium Assay Product Overview
Idylla Endpoint CDx Test
Idylla Endpoint CDx Test Product Overview
Idylla Extended KRAS Mutation Test
Idylla Extended KRAS Mutation Test Product Overview
Idylla Extended NRAS Mutation Test
Idylla Extended NRAS Mutation Test Product Overview
Idylla Gene Fusion Assay
Idylla Gene Fusion Assay Product Overview
Idylla Hematology Assay
Idylla Hematology Assay Product Overview
Idylla HPV Test – Head & Neck Cancer
Idylla HPV Test – Head & Neck Cancer Product Overview
Idylla Immuno Tx Panel Test
Idylla Immuno Tx Panel Test Product Overview
Idylla KRAS Mutation Test
Idylla KRAS Mutation Test Product Overview
Idylla Meningitis Assay
Idylla Meningitis Assay Product Overview
Idylla MERS Assay
Idylla MERS Assay Product Overview
Idylla MSI CDx
Idylla MSI CDx Product Overview
Idylla MSI Test
Idylla MSI Test Product Overview
Idylla Multiplex Respiratory Panel
Idylla Multiplex Respiratory Panel Product Overview
Idylla Neuro Panel Test
Idylla Neuro Panel Test Product Overview
Idylla Neurological Disease Assay
Idylla Neurological Disease Assay Product Overview
Idylla NGS Prep Panel – Lung
Idylla NGS Prep Panel – Lung Product Overview
Idylla NRAS Mutation Test
Idylla NRAS Mutation Test Product Overview
Idylla NRAS-BRAF Mutation Test
Idylla NRAS-BRAF Mutation Test Product Overview
Idylla Oncotype DX Prostate
Idylla Oncotype DX Prostate Product Overview
Idylla Resistance Monitoring Assay
Idylla Resistance Monitoring Assay Product Overview
Idylla Retrieve – NGS Hotspot Panel Assay
Idylla Retrieve – NGS Hotspot Panel Assay Product Overview
Idylla Sepsis Assay
Idylla Sepsis Assay Product Overview
Idylla Syndromic Immunocompromised Panel
Idylla Syndromic Immunocompromised Panel Product Overview
Idylla Syndromic Panel – Tropical Fever
Idylla Syndromic Panel – Tropical Fever Product Overview
Idylla System – Multiplex Companion Diagnostics Test
Idylla System – Multiplex Companion Diagnostics Test Product Overview
Idylla Test – Cell Therapy Monitoring
Idylla Test – Cell Therapy Monitoring Product Overview
Idylla Viral Load Assay – HBV
Idylla Viral Load Assay – HBV Product Overview
Idylla Viral Load Assay – HCV
Idylla Viral Load Assay – HCV Product Overview
Idylla Viral Load Assay – HIV
Idylla Viral Load Assay – HIV Product Overview
Idylla-ctBRAF Test – Melanoma
Idylla-ctBRAF Test – Melanoma Product Overview
SeptiCyte Triage
SeptiCyte Triage Product Overview
Biocartis Group NV – Key Competitors
Biocartis Group NV – Key Employees
Biocartis Group NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biocartis Group NV, Recent Developments
Mar 05, 2020: Biocartis Group: Biocartis announces 2019 results and 2020 outlook
Mar 05, 2020: Biocartis announces new immuno-oncology project with Bristol-Myers Squibb aimed at registration of Idylla MSI test in China
Jan 27, 2020: Biocartis announces resignation CFO
Jan 09, 2020: Biocartis meets 2019 key business objectives
Nov 14, 2019: Biocartisb Q3 2019 business update
Nov 14, 2019: Biocartis Q3 2019 business update
Oct 28, 2019: Biocartis launches liquid biopsy testing Idylla ctEGFR Mutation Assay
Sep 23, 2019: Five Idylla Performance Studies to be Presented at ‘European Society for Medical Oncology’ congress
Sep 05, 2019: Biocartis announces H1 2019 results
Aug 05, 2019: Study on performance data of Idylla NRAS-BRAF Mutation Assay at 71st AACC Annual Scientific Meeting in Anaheim, CA (US)
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview
Biocartis Group NV Pipeline Products by Equipment Type
Biocartis Group NV Pipeline Products by Indication
Biocartis Group NV, Key Facts
Biocartis Group NV, Major Products and Services
Biocartis Group NV Number of Pipeline Products by Development Stage
Biocartis Group NV Pipeline Products Summary by Development Stage
EGFR Colon Cancer Test - Product Status
EGFR Colon Cancer Test - Product Description
Idylla - EGFR/BRAF+ Test - Product Status
Idylla - EGFR/BRAF+ Test - Product Description
Idylla - KRAS-NRAS-BRAF Test - Product Status
Idylla - KRAS-NRAS-BRAF Test - Product Description
Idylla ABC Assay - Product Status
Idylla ABC Assay - Product Description
Idylla Blood Stream Infections Panel - Product Status
Idylla Blood Stream Infections Panel - Product Description
Idylla Companion Diagnostic Assay - Product Status
Idylla Companion Diagnostic Assay - Product Description
Idylla ctEGFR Assay - Product Status
Idylla ctEGFR Assay - Product Description
Idylla Endometrium Assay - Product Status
Idylla Endometrium Assay - Product Description
Idylla Endpoint CDx Test - Product Status
Idylla Endpoint CDx Test - Product Description
Idylla Extended KRAS Mutation Test - Product Status
Idylla Extended KRAS Mutation Test - Product Description
Idylla Extended NRAS Mutation Test - Product Status
Idylla Extended NRAS Mutation Test - Product Description
Idylla Gene Fusion Assay - Product Status
Idylla Gene Fusion Assay - Product Description
Idylla Hematology Assay - Product Status
Idylla Hematology Assay - Product Description
Idylla HPV Test - Head & Neck Cancer - Product Status
Idylla HPV Test - Head & Neck Cancer - Product Description
Idylla Immuno Tx Panel Test - Product Status
Idylla Immuno Tx Panel Test - Product Description
Idylla KRAS Mutation Test - Product Status
Idylla KRAS Mutation Test - Product Description
Idylla Meningitis Assay - Product Status
Idylla Meningitis Assay - Product Description
Idylla MERS Assay - Product Status
Idylla MERS Assay - Product Description
Idylla MSI CDx - Product Status
Idylla MSI CDx - Product Description
Idylla MSI Test - Product Status
Idylla MSI Test - Product Description
Idylla Multiplex Respiratory Panel - Product Status
Idylla Multiplex Respiratory Panel - Product Description
Idylla Neuro Panel Test - Product Status
Idylla Neuro Panel Test - Product Description
Idylla Neurological Disease Assay - Product Status
Idylla Neurological Disease Assay - Product Description
Idylla NGS Prep Panel - Lung - Product Status
Idylla NGS Prep Panel - Lung - Product Description
Idylla NRAS Mutation Test - Product Status
Idylla NRAS Mutation Test - Product Description
Idylla NRAS-BRAF Mutation Test - Product Status
Idylla NRAS-BRAF Mutation Test - Product Description
Idylla Oncotype DX Prostate - Product Status
Idylla Oncotype DX Prostate - Product Description
Idylla Resistance Monitoring Assay - Product Status
Idylla Resistance Monitoring Assay - Product Description
Idylla Retrieve - NGS Hotspot Panel Assay - Product Status
Idylla Retrieve - NGS Hotspot Panel Assay - Product Description
Idylla Sepsis Assay - Product Status
Idylla Sepsis Assay - Product Description
Idylla Syndromic Immunocompromised Panel - Product Status
Idylla Syndromic Immunocompromised Panel - Product Description
Idylla Syndromic Panel - Tropical Fever - Product Status
Idylla Syndromic Panel - Tropical Fever - Product Description
Idylla System - Multiplex Companion Diagnostics Test - Product Status
Idylla System - Multiplex Companion Diagnostics Test - Product Description
Idylla Test - Cell Therapy Monitoring - Product Status
Idylla Test - Cell Therapy Monitoring - Product Description
Idylla Viral Load Assay - HBV - Product Status
Idylla Viral Load Assay - HBV - Product Description
Idylla Viral Load Assay - HCV - Product Status
Idylla Viral Load Assay - HCV - Product Description
Idylla Viral Load Assay - HIV - Product Status
Idylla Viral Load Assay - HIV - Product Description
Idylla-ctBRAF Test - Melanoma - Product Status
Idylla-ctBRAF Test - Melanoma - Product Description
SeptiCyte Triage - Product Status
SeptiCyte Triage - Product Description
Biocartis Group NV, Key Employees
Biocartis Group NV, Subsidiaries
Glossary

★海外企業調査レポート[Biocartis Group NV (BCART)：企業の製品パイプライン分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Birchcliff Energy Ltd (BIR)-石油・ガス分野：企業M&A・提携分析
    Summary Birchcliff Energy Ltd. (Birchcliff) is an intermediate oil and gas company that explores for, develops and produces natural gas, light oil and natural gas liquids. It operates in the Peace River Arch area to the northwest of Grande Prairie, Alberta. Peach River Arch region is one of the pote …
  • NRG Energy Inc (NRG)：企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Giordano International Limited (709)：企業の財務・戦略的SWOT分析
    Giordano International Limited (709) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Elephant Oil Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary Elephant Oil Ltd (Elephant Oil) is an oil and gas company. The company provides services such as exploration and production of oil and natural gas. It provides its exploration services in the underexplored areas of West Africa. Elephant Oil holds interest in a production-sharing contract in …
  • Matica Technologies AG：企業の戦略的SWOT分析
    Matica Technologies AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Empresa Electricidad del Peru SA (ELECPBC1)：企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • MTR Corporation Ltd：戦略・SWOT・企業財務分析
    MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Lightbridge Corporation (LTBR)：企業の財務・戦略的SWOT分析
    Lightbridge Corporation (LTBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Alembic Pharmaceuticals Ltd (APLLTD)：企業の財務・戦略的SWOT分析
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • Krystal Biotech Inc (KRYS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Krystal Biotech Inc (Krystal Biotech) is a drug development company that uses gene therapy to develop novel treatments for skin diseases. The company’s pipeline products include KB103, KB105, and KB200. Its products are used for the treatment of dystrophic EB, TGM1-deficient autosomal recess …
  • Intellia Therapeutics Inc (NTLA)：企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Iron Bridge Resources Inc (RMP)：石油・ガス：M&Aディール及び事業提携情報
    Summary Iron Bridge Resources Inc (Iron Bridge Resources), formerly RMP Energy Inc, Inc is an upstream oil and gas exploration and development company that acquires, develops, explores and produces natural gas and natural gas liquid in Western Canada. The company’s properties produce oil, gas liquid …
  • Transmetro Corporation Limited：企業の戦略・SWOT・財務分析
    Transmetro Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Transmetro Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Sherwin-Williams Company：企業の戦略・SWOT・財務分析
    The Sherwin-Williams Company - Strategy, SWOT and Corporate Finance Report Summary The Sherwin-Williams Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Dais Analytic Corps (DLYT)：企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …
  • Driver and Vehicle Standards Agency：企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Accord Financial Corp. (ACD)：企業の財務・戦略的SWOT分析
    Accord Financial Corp. (ACD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Telefonica, S.A.：企業の戦略・SWOT・財務情報
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Peregrine Holdings Ltd：企業の戦略・SWOT・財務分析
    Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Myriad Genetics Inc (MYGN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆